BCA
BDSI

Berman Capital Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Berman Capital Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-73
Closed – – 2122
2021
Q1 		$0 Hold
73
– – ﹤0.01% 1983
2020
Q4 		$0 Buy
+73
New +$281 ﹤0.01% 1921

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Berman Capital Advisors's BDSI Position: Q2 2021 in Review

Berman Capital Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2021, closing a stake of 73 shares.

Berman Capital Advisors first reported a position in BDSI in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2021.

  • Berman Capital Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2021 after selling out during the quarter.
  • Berman Capital Advisors sold 73 BioDelivery Sciences International, Inc. shares in Q2 2021.
  • Berman Capital Advisors first reported a position in BioDelivery Sciences International, Inc. in Q4 2020 and held it in 2 quarters.
  • Berman Capital Advisors's BioDelivery Sciences International, Inc. position peaked at $0 in Q1 2021.
  • 143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2021.

Based on Berman Capital Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.